In a recent discussion with The Clinical Trial Vanguard, CuriMeta’s Chief Data Officer, Craig White, discussed the transformative role of real-world data in reshaping clinical trials. Established in collaboration with renowned institutions, CuriMeta harnesses a vast dataset from academic medical centers, offering insights from medical records to pathology and radiology data. Curimeta’s mission is to provide a comprehensive view of patient care, capturing intricate nuances across various medical departments.The conversation further highlights the increasing significance of real-world data in clinical trials, especially following the 21st Century Cures Act. From identifying unmet medical needs to streamlining patient recruitment and ensuring diverse representation in trials, real-world data is set to play a pivotal role in the future of clinical research. For a deeper understanding and insights from Curimeta’s own industry expert, read the full article here.